RA Capital Healthcare Fund LP's Form 4 filing
Fulcrum Therapeutics, Inc. (FULC) · filed Dec 10, 2025
- Accession no.
- 0001231919-25-000596
- Filed
- Dec 10, 2025, 4:42 PM ET
- Trade date
- Dec 8, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $58.4M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| RA Capital Healthcare Fund LPCIK 0001315082 | 10% Owner |
| Ra Capital Management, L.P.CIK 0001346824 | 10% Owner |
| Kolchinsky PeterCIK 0001384859 | 10% Owner |
| Shah Rajeev M.CIK 0001619841 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Common Stock | SSaleDisposed | −1,377,020 | $13.33 | −$18,355,676.6 | 8,852,079 | Indirect | |
| Dec 8, 2025 | Common Stock | SSaleDisposed | −2,706,397 | $14.28 | −$38,647,349.16 | 6,145,682 | Indirect | |
| Dec 8, 2025 | Common Stock | SSaleDisposed | −91,722 | $14.98 | −$1,373,995.56 | 6,053,960 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.